Accelerated-Learning-Online.com - helping you learn faster
Home | Contact Us
Search Site:
 
Home
Learning State
Learning Process
Memory Techniques
Learning Styles
Learning Approach
Learning Challenges
Other Resources
Research Articles
Brain News
Contact Us

Research article summary:

The impact of drugs against dementia on cognition in aging and mild cognitive impairment.

Abstract Extract:
OBJECTIVE: To define the actual knowledge of the impact of drugs for the treatment of dementia on the improvement of cognition in aging and mild cognitive impairment. METHOD: We conducted a Medline search for studies with the parameters drug and ... (Full abstract text below)

Published 2003Jun in Journal: Pharmacopsychiatry (Language : eng)

Full Pubmed Extract

This information was retrieved, real-time, on your behalf from the public area of the Pubmed website:

1. Pharmacopsychiatry. 2003 Jun;36 Suppl 1():S38-43

The impact of drugs against dementia on cognition in aging and mild cognitive impairment.

Ihl R

Department of Psychiatry, University of Düsseldorf, Germany.

OBJECTIVE: To define the actual knowledge of the impact of drugs for the treatment of dementia on the improvement of cognition in aging and mild cognitive impairment. METHOD: We conducted a Medline search for studies with the parameters drug and cognition. Only drugs that had demonstrated cognition improvements in dementia according to actual methodological standards were included. Drugs had to be approved in at least one American or European nation. RESULTS: Donepezil, galantamine, Ginkgo biloba EGb 761 (definition see editorial), memantine and rivastigmine fulfilled these criteria. There were no systematic investigations on the effects of these drugs on cognition in healthy adults or patients with mild cognitive impairment (MCI). Regarding Ginkgo biloba, two studies on MCI patients could be identified. In healthy adults, we could only include one study investigating donepezil and seven investigating Ginkgo biloba EGb 761. According to the findings, donepezil significantly increased the percentage of REM sleep and REM density, whereas REM latency was reduced. This was interpreted as a sign of improved cognition. Ginkgo biloba EGb 761 improved cognition in healthy controls according to Delayed Free Recall and Delayed Recognition of the WAIS-III and the Color Naming of the Stroop Test as well as in MCI in Digit Copying, Dual Coding Task and speed of response on a computerized version of a classification task. The highest effects were observed after 6 weeks of treatment with 180 mg/d. CONCLUSIONS: Due to the lack of standard procedures for investigating cognition improvement in healthy aging, results have to be interpreted cautiously. In healthy adults as well as in individuals categorized as having MCI, Ginkgo biloba EGb 761 improved cognition in some but not all neuropsychological tests. The single positive result with donepezil raises hope that other drugs may also contribute to cognitive improvement, even in healthy adults. However, the data do not allow any conclusions regarding an improvement following a specific "neuropsychological cluster." Studies on prevention have not been completed so far.

PMID : 13130387 [PubMed - Indexed for MEDLINE]


This information is obtained from the National Library of Medicine (NLM). Abstract text and other information may be subject to copyright. Type "NLM copyright" into Google for more information.

Full Author Information

First NameLastNameInitials
RIhlR

Affiliation: Department of Psychiatry, University of Düsseldorf, Germany.

3rd Party provider links

Click the links below to go to related 3rd party information:

MESH categories and related page links

This article was linked to the MESH categories shown on the left below. The links on the right are related Memletics pages.

Category links from this article:

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging - physiology
  • Cognition - drug effects
  • Cognition Disorders - drug therapy, etiology
  • Dementia - complications, drug therapy
  • Female
  • Galantamine - therapeutic use
  • Ginkgo biloba
  • Humans
  • Indans - therapeutic use
  • MEDLINE - statistics & numerical data
  • Male
  • Middle Aged
  • Nootropic Agents - therapeutic use
  • Piperidines - therapeutic use
  • Plant Extracts - therapeutic use
   

Related Memletics topics:

Links for this article

For links to places where you can get the full text of this article see links. Note there may be a subscription or fee required for access to the full text.

New! Using similar technology to this site, we have launched find-health-articles.com, targeting over 1 million health research article abstracts.

Related Articles

Here are some articles related to this one (by title keywords):

Keywords in this article:

according, actual, adults, after, aging, allow, american, approved, biloba, categorized, cautiously, classification, cluster, coding, cognition, cognitive, color, completed, computerized, conclusions, conducted, contribute, controls, copying, criteria, data, define, definition, delayed, dementia, demonstrated, density, digit, donepezil, drugs, dual, editorial, effects, egb, european, findings, following, free, fulfilled, galantamine, ginkgo, healthy, highest, hope, identified, iii, impact, impairment, improved, improvement, improvements, included, increased, individuals, interpreted, investigating, investigations, knowledge, lack, latency, least, mci, medline, memantine, method, methodological, mild, naming, nation, neuropsychological, not, objective, observed, one, only, other, parameters, patients, percentage, positive, prevention, procedures, raises, recall, recognition, reduced, rem, response, results, rivastigmine, search, see, seven, sign, single, sleep, specific, speed, standards, stroop, studies, study, systematic, task, test, tests, treatment, two, version, wais, weeks, well, whereas

Also, see our new free speed reading online course (beta version)

© Advanogy.com 2003-2007 - All rights reserved. Terms of Use | Privacy Statement | Contact Us